cuts patient cost of EpiPen
Send a link to a friend
[August 25, 2016]
(Reuters) - Mylan NV said on
Thursday it would reduce the out-of-pocket cost of its severe allergy
treatment EpiPen, a day after Democratic Presidential candidate Hillary
Clinton joined other lawmakers in criticizing the high price of the
The company said it would reduce the patient cost of EpiPen through
the use of a savings card, which will cover up to $300 of EpiPen
Price of the product, which Mylan acquired in 2007, has zoomed to
$600 from $100 in 2008.
For patients previously paying the full amount of the company's list
price, the card effectively reduces their out-of-pocket cost
exposure by 50 percent, Mylan said.
The company said it is also doubling the eligibility for its patient
assistance program, which will eliminate out-of-pocket costs for
uninsured and under-insured patients and families.
Clinton on Wednesday called on Mylan to voluntarily drop the price
Clinton's comments came after a bipartisan group of lawmakers called
for investigations into the price increase of EpiPens, which are
preloaded injections of epinephrine (adrenaline) that people use if
they are having a dangerous allergic reaction that untreated could
result in death.
[to top of second column]
On Wednesday, Republican Senator Susan Collins and Democratic
Senator Claire McCaskill requested that Mylan provide a briefing for
the Senate to explain the price change.
Mylan's shares were up 3.6 percent at $44.67 in premarket trading on
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj
[© 2016 Thomson Reuters. All rights
Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.